ConductScience.org, home

Paper40824482

Cell cycle regulation in cancer cells by O-GlcNAcylation.

González-González U and 5 others. Glycoconj J, 2025. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Cell cycle regulation in cancer cells by O-GlcNAcylation. Papers, record 40824482. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40824482

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cell cycle regulation in cancer cells by O-GlcNAcylation.
PubMed
Journal
Glycoconj J
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2026-11-05
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1González-González UUliseshttps://orcid.org/0000-0001-6645-4740
2Castañeda-Patlán MCMaría Cristinahttps://orcid.org/0000-0002-2551-4847
3Hernández-Huerta MTMaría Teresahttps://orcid.org/0000-0003-2182-2540
4Hernández-Juárez JJesúshttps://orcid.org/0000-0002-5505-1097
5Zenteno-Galindo EEdgarhttps://orcid.org/0000-0001-5603-4072
6Solórzano-Mata CJCarlos Josuéhttps://orcid.org/0000-0002-5735-0373

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cell CycleMajor topic
N-AcetylglucosaminyltransferasesMajor topic
Protein Processing, Post-TranslationalMajor topic
NeoplasmsMajor topic
HexosaminesMajor topic
Protein Stability
Phosphatidylinositol 3-Kinases
Proto-Oncogene Proteins c-akt
Acylation
Humans

Source PubMed

Download CSV of topics

References123

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135123658The hallmarks of cancer metabolism: Still emerging.Cell Metab2022https://conductscience.org/library/papers/35123658PubMed
240148026Cell cycle dysregulation in cancer.Pharmacol Rev2025https://conductscience.org/library/papers/40148026PubMed
322275356Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis.J Biol Chem2012https://conductscience.org/library/papers/22275356PubMed
430849534The relation between PI3K/AKT signalling pathway and cancer.Gene2019https://conductscience.org/library/papers/30849534PubMed
538110988Protein O-GlcNAcylation: The sweet hub in liver metabolic flexibility from a (patho)physiological perspective.Liver Int2024https://conductscience.org/library/papers/38110988PubMed
633215629Inhibition of mechanistic target of rapamycin signaling decreases levels of O-GlcNAc transferase and increases serotonin release in the human placenta.Clin Sci (Lond)2020https://conductscience.org/library/papers/33215629PubMed
723552487Serum-stimulated cell cycle entry promotes ncOGT synthesis required for cyclin D expression.Oncogenesis2012https://conductscience.org/library/papers/23552487PubMed
821840999Hyperglycemia-induced O-GlcNAcylation and truncation of 4E-BP1 protein in liver of a mouse model of type 1 diabetes.J Biol Chem2011https://conductscience.org/library/papers/21840999PubMed
930715269O-GlcNAcylation of YY1 stimulates tumorigenesis in colorectal cancer cells by targeting SLC22A15 and AANAT.Carcinogenesis2019https://conductscience.org/library/papers/30715269PubMed
1039584065β-Ketoenamine covalent organic framework nanoplatform combined with immune checkpoint blockade via photodynamic immunotherapy inhibit glioblastoma progression.Bioact Mater2025https://conductscience.org/library/papers/39584065PubMed
1122481935Akt: a double-edged sword in cell proliferation and genome stability.J Oncol2012https://conductscience.org/library/papers/22481935PubMed
1230105004O-GlcNAc: A Sweetheart of the Cell Cycle and DNA Damage Response.Front Endocrinol (Lausanne)2018https://conductscience.org/library/papers/30105004PubMed
1322629392Extensive crosstalk between O-GlcNAcylation and phosphorylation regulates Akt signaling.PLoS One2012https://conductscience.org/library/papers/22629392PubMed
1439337387O-GlcNAcylation: Crosstalk between Hemostasis, Inflammation, and Cancer.Int J Mol Sci2024https://conductscience.org/library/papers/39337387PubMed
1516244361Identification of the major site of O-linked beta-N-acetylglucosamine modification in the C terminus of insulin receptor substrate-1.Mol Cell Proteomics2006https://conductscience.org/library/papers/16244361PubMed
1630952976O-GlcNAc Transferase Inhibition Differentially Affects Breast Cancer Subtypes.Sci Rep2019https://conductscience.org/library/papers/30952976PubMed
1716964247Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability.Nat Cell Biol2006https://conductscience.org/library/papers/16964247PubMed
1826080840Genome Analysis of Latin American Cervical Cancer: Frequent Activation of the PIK3CA Pathway.Clin Cancer Res2015https://conductscience.org/library/papers/26080840PubMed
193927693214-3-3ε augments OGT stability by binding with S20-phosphorylated OGT.J Biol Chem2024https://conductscience.org/library/papers/39276932PubMed
2038462164O-GlcNAcylation stimulates the deubiquitination activity of USP16 and regulates cell cycle progression.J Biol Chem2024https://conductscience.org/library/papers/38462164PubMed

See all 123 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42078454A study on bile from patients with recurrent common bile duct stones and cholangiocarcinoma following ERCP using non-targeted metabolomics.Front Med (Lausanne)2026https://conductscience.org/library/papers/42078454PubMed
41692895Tumor cell cycle regulation: integrated perspective of stage characteristics, regulatory networks, and signaling pathway intervention strategies.Mol Biomed2026https://conductscience.org/library/papers/41692895PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
PIK3CB5291PubTator's text mininghttps://conductscience.org/library/genes/5291NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40824482

GET https://conductscience.org/api/papers/v1/40824482/references?page=2